Proteome Sciences plc (PMSNF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 14.58 Million USD | -3.0% |
| 2022 | 15.03 Million USD | 10.73% |
| 2021 | 13.57 Million USD | 9.25% |
| 2020 | 12.42 Million USD | 12.22% |
| 2019 | 11.07 Million USD | 23.76% |
| 2018 | 8.94 Million GBP | -11.52% |
| 2017 | 10.11 Million GBP | -15.61% |
| 2016 | 11.98 Million GBP | -6.84% |
| 2015 | 12.86 Million GBP | 55.16% |
| 2014 | 8.29 Million GBP | 17.53% |
| 2013 | 7.05 Million GBP | 1.52% |
| 2012 | 6.94 Million GBP | -36.3% |
| 2011 | 10.9 Million GBP | -30.05% |
| 2010 | 15.59 Million GBP | 151.61% |
| 2009 | 6.19 Million GBP | -3.79% |
| 2008 | 6.44 Million GBP | -2.86% |
| 2007 | 6.63 Million GBP | 3.71% |
| 2006 | 6.39 Million GBP | -33.21% |
| 2005 | 9.57 Million GBP | -7.42% |
| 2004 | 10.34 Million GBP | -28.3% |
| 2003 | 14.42 Million GBP | 4.35% |
| 2002 | 13.82 Million GBP | 268.96% |
| 2001 | 3.74 Million GBP | -11.1% |
| 2000 | 4.21 Million GBP | 425.56% |
| 1999 | 802 Thousand GBP | -57.63% |
| 1998 | 1.89 Million GBP | -44.63% |
| 1997 | 3.41 Million GBP | 464.19% |
| 1996 | 606 Thousand GBP | -66.9% |
| 1995 | 1.83 Million GBP | 338.04% |
| 1994 | 418 Thousand GBP | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 11.95 Million USD | 0.0% |
| 2023 Q4 | 14.58 Million USD | 4.34% |
| 2023 Q3 | 13.97 Million GBP | -0.75% |
| 2023 Q1 | 13.68 Million GBP | -8.96% |
| 2023 FY | 14.58 Million USD | -3.0% |
| 2023 Q2 | 14.08 Million USD | 2.89% |
| 2022 Q3 | 13.88 Million GBP | 4.03% |
| 2022 Q2 | 13.34 Million GBP | -7.35% |
| 2022 Q4 | 15.03 Million USD | 8.3% |
| 2022 Q1 | 14.4 Million GBP | 6.08% |
| 2022 FY | 15.03 Million USD | 10.73% |
| 2021 Q3 | 13.53 Million GBP | 12.7% |
| 2021 Q1 | 11.98 Million GBP | -3.58% |
| 2021 FY | 13.57 Million USD | 9.25% |
| 2021 Q4 | 13.57 Million GBP | 0.32% |
| 2021 Q2 | 12.01 Million GBP | 0.21% |
| 2020 Q3 | 11.73 Million GBP | 18.52% |
| 2020 Q1 | 9.96 Million GBP | -10.07% |
| 2020 Q2 | 9.89 Million GBP | -0.62% |
| 2020 Q4 | 12.42 Million GBP | 5.94% |
| 2020 FY | 12.42 Million USD | 12.22% |
| 2019 Q2 | 10.1 Million GBP | -2.28% |
| 2019 FY | 11.07 Million USD | 23.76% |
| 2019 Q1 | 10.34 Million GBP | 47.18% |
| 2019 Q4 | 11.07 Million GBP | 7.74% |
| 2019 Q3 | 10.28 Million GBP | 1.72% |
| 2018 FY | 8.94 Million GBP | -11.52% |
| 2018 Q2 | 6.17 Million GBP | -28.73% |
| 2018 Q1 | 8.66 Million GBP | 15.89% |
| 2018 Q3 | 9.15 Million GBP | 48.29% |
| 2018 Q4 | 7.02 Million GBP | -23.27% |
| 2017 Q4 | 7.47 Million GBP | -25.36% |
| 2017 Q3 | 10.01 Million GBP | 19.91% |
| 2017 Q2 | 8.35 Million GBP | -20.19% |
| 2017 FY | 10.11 Million GBP | -15.61% |
| 2017 Q1 | 10.46 Million GBP | 7.91% |
| 2016 Q1 | 10.73 Million GBP | 22.96% |
| 2016 Q4 | 9.7 Million GBP | -22.86% |
| 2016 Q2 | 7.45 Million GBP | -30.57% |
| 2016 FY | 11.98 Million GBP | -6.84% |
| 2016 Q3 | 12.57 Million GBP | 68.74% |
| 2015 Q4 | 8.72 Million GBP | -33.91% |
| 2015 Q1 | 13.75 Million GBP | 65.83% |
| 2015 FY | 12.86 Million GBP | 55.16% |
| 2015 Q3 | 13.2 Million GBP | 42.71% |
| 2015 Q2 | 9.25 Million GBP | -32.69% |
| 2014 Q3 | 13.45 Million GBP | 33.28% |
| 2014 FY | 8.29 Million GBP | 17.53% |
| 2014 Q2 | 10.09 Million GBP | -40.0% |
| 2014 Q1 | 16.82 Million GBP | 138.44% |
| 2014 Q4 | 8.29 Million GBP | -38.35% |
| 2013 FY | 7.05 Million GBP | 1.52% |
| 2013 Q2 | 6.75 Million GBP | -34.14% |
| 2013 Q1 | 10.26 Million GBP | 47.66% |
| 2013 Q4 | 7.05 Million GBP | -38.23% |
| 2013 Q3 | 11.42 Million GBP | 69.02% |
| 2012 Q4 | 6.94 Million GBP | 0.0% |
| 2012 FY | 6.94 Million GBP | -36.3% |
| 2012 Q2 | 9.83 Million GBP | 0.0% |
| 2011 FY | 10.9 Million GBP | -30.05% |
| 2011 Q4 | 10.9 Million GBP | 0.0% |
| 2011 Q2 | 12.98 Million GBP | 0.0% |
| 2010 Q4 | 15.59 Million GBP | 0.0% |
| 2010 Q2 | 11.65 Million GBP | 0.0% |
| 2010 FY | 15.59 Million GBP | 151.61% |
| 2009 Q2 | 5.92 Million GBP | 0.0% |
| 2009 FY | 6.19 Million GBP | -3.79% |
| 2009 Q4 | 6.19 Million GBP | 0.0% |
| 2008 FY | 6.44 Million GBP | -2.86% |
| 2008 Q4 | 6.44 Million GBP | 0.0% |
| 2008 Q2 | 6.27 Million GBP | 0.0% |
| 2007 Q2 | 6.61 Million GBP | 0.0% |
| 2007 FY | 6.63 Million GBP | 3.71% |
| 2007 Q4 | 6.63 Million GBP | 0.0% |
| 2006 Q4 | 6.39 Million GBP | 0.0% |
| 2006 Q2 | 7.67 Million GBP | 0.0% |
| 2006 FY | 6.39 Million GBP | -33.21% |
| 2005 Q2 | 12.28 Million GBP | 0.0% |
| 2005 Q4 | 9.57 Million GBP | 0.0% |
| 2005 FY | 9.57 Million GBP | -7.42% |
| 2004 Q2 | 13.69 Million GBP | 0.0% |
| 2004 Q4 | 10.34 Million GBP | 0.0% |
| 2004 FY | 10.34 Million GBP | -28.3% |
| 2003 FY | 14.42 Million GBP | 4.35% |
| 2002 FY | 13.82 Million GBP | 268.96% |
| 2001 FY | 3.74 Million GBP | -11.1% |
| 2000 FY | 4.21 Million GBP | 425.56% |
| 1999 FY | 802 Thousand GBP | -57.63% |
| 1998 FY | 1.89 Million GBP | -44.63% |
| 1997 FY | 3.41 Million GBP | 464.19% |
| 1996 FY | 606 Thousand GBP | -66.9% |
| 1995 FY | 1.83 Million GBP | 338.04% |
| 1994 FY | 418 Thousand GBP | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -1049.412% |
| Arrayit Corporation | 1 Million USD | -1358.036% |
| Atlantic International Corp. | 4.43 Million USD | -228.784% |
| Biocept, Inc. | 30.87 Million USD | 52.755% |
| Bioqual, Inc. | 56.58 Million USD | 74.224% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -6188.926% |
| DermTech, Inc. | 121.93 Million USD | 88.037% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.651% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 17.953% |
| iMD Companies, Inc. | 190.13 Thousand USD | -7571.328% |
| IDenta Corp. | 1.52 Million USD | -853.787% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -12.019% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -76.759% |
| InVitro International | 1.53 Million USD | -850.845% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 45.652% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -630783.78% |
| Medical Imaging Corp. | 4.19 Million USD | -247.98% |
| NovelStem International Corp. | 2.25 Million USD | -546.961% |
| Optigenex Inc. | 1.88 Million USD | -672.447% |
| PharmChem, Inc. | 2.76 Million USD | -427.417% |
| Response Genetics, Inc | 48.88 Million USD | 70.162% |
| Rennova Health, Inc. | 20.57 Million USD | 29.1% |
| RushNet, Inc. | 6.04 Million USD | -141.187% |
| ScreenPro Security Inc. | 1.26 Million USD | -1056.374% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -2987.494% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -1981.78% |
| Todos Medical Ltd. | 15.26 Million USD | 4.46% |